369 related articles for article (PubMed ID: 16482731)
1. Ovarian cancer screening: a look at the evidence.
Fields MM; Chevlen E
Clin J Oncol Nurs; 2006 Feb; 10(1):77-81. PubMed ID: 16482731
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
3. ACR appropriateness criteria© ovarian cancer screening.
Brown DL; Andreotti RF; Lee SI; Dejesus Allison SO; Bennett GL; Dubinsky T; Glanc P; Horrow MM; Lev-Toaff AS; Horowitz NS; Podrasky AE; Scoutt LM; Zelop CM
Ultrasound Q; 2010 Dec; 26(4):219-23. PubMed ID: 21084936
[TBL] [Abstract][Full Text] [Related]
4. Screening and detection of ovarian cancer.
Breedlove G; Busenhart C
J Midwifery Womens Health; 2005; 50(1):51-4. PubMed ID: 15637515
[TBL] [Abstract][Full Text] [Related]
5. Ovarian intraepithelial neoplasia and ovarian cancer.
Gershenson DM; Tortolero-Luna G; Malpica A; Baker VV; Whittaker L; Johnson E; Follen Mitchell M
Obstet Gynecol Clin North Am; 1996 Jun; 23(2):475-543. PubMed ID: 8784888
[TBL] [Abstract][Full Text] [Related]
6. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
[TBL] [Abstract][Full Text] [Related]
7. Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.
Jurisicova A; Jurisica I; Kislinger T
Expert Rev Proteomics; 2008 Aug; 5(4):551-60. PubMed ID: 18761466
[TBL] [Abstract][Full Text] [Related]
8. Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
Baron AT; Cora EM; Lafky JM; Boardman CH; Buenafe MC; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):103-13. PubMed ID: 12582019
[TBL] [Abstract][Full Text] [Related]
9. Introducing the MUC16 gene: implications for prevention and early detection in epithelial ovarian cancer.
McLemore MR; Aouizerat B
Biol Res Nurs; 2005 Apr; 6(4):262-7. PubMed ID: 15788735
[TBL] [Abstract][Full Text] [Related]
10. Women's awareness of ovarian cancer risks and symptoms.
Lockwood-Rayermann S; Donovan HS; Rambo D; Kuo CW
Am J Nurs; 2009 Sep; 109(9):36-45; quiz 46. PubMed ID: 19704232
[TBL] [Abstract][Full Text] [Related]
11. [Early detection and preoperative diagnosis of ovarian carcinoma].
Kainz C
Wien Med Wochenschr; 1996; 146(1-2):2-7. PubMed ID: 8835487
[TBL] [Abstract][Full Text] [Related]
12. Strategies for ovarian cancer prevention.
Dann RB; Kelley JL; Zorn KK
Obstet Gynecol Clin North Am; 2007 Dec; 34(4):667-86, viii. PubMed ID: 18061863
[TBL] [Abstract][Full Text] [Related]
13. [Screening for ovarian cancer in BRCA1/BRCA2 mutations carriers].
Synowiec A; Wcisło G; Bodnar L; Gasowska-Bodnar A; Szczylik C
Ginekol Pol; 2014 May; 85(5):377-81. PubMed ID: 25011220
[TBL] [Abstract][Full Text] [Related]
14. [Ovarian cancer screening: recommendations for clinical pratice].
Amram-Benamran ML; Cochet S; Petignat P; Sappino AP
Rev Med Suisse; 2010 May; 6(250):1062, 1064, 1066-8. PubMed ID: 20564865
[TBL] [Abstract][Full Text] [Related]
15. Progress report on ovarian cancer screening. Scientists are making headway in detecting ovarian cancer at an earlier stage.
Harv Womens Health Watch; 2010 Apr; 17(8):1-3. PubMed ID: 20506601
[No Abstract] [Full Text] [Related]
16. [Screening for ovarian cancers: critical analysis].
Pennehouat G; Gugliemina JN; Naouri M; Créquat J; Bouret JM; Thébault Y; Madelenat P
Contracept Fertil Sex; 1993 Mar; 21(3):223-30. PubMed ID: 7951617
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of the Stockholm screening study on ovarian cancer.
Einhorn N; Bast R; Knapp R; Nilsson B; Zurawski V; Sjövall K
Gynecol Oncol; 2000 Dec; 79(3):466-70. PubMed ID: 11104621
[TBL] [Abstract][Full Text] [Related]
18. Early detection of breast and ovarian cancer in families with BRCA mutations.
Vasen HF; Tesfay E; Boonstra H; Mourits MJ; Rutgers E; Verheyen R; Oosterwijk J; Beex L
Eur J Cancer; 2005 Mar; 41(4):549-54. PubMed ID: 15737559
[TBL] [Abstract][Full Text] [Related]
19. Screening for ovarian cancer: what we know, what we need to know.
Hensley ML; Castiel M; Robson ME
Oncology (Williston Park); 2000 Nov; 14(11):1601-7; discussion 1608, 1613-6. PubMed ID: 11125943
[TBL] [Abstract][Full Text] [Related]
20. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.
Skates SJ; Menon U; MacDonald N; Rosenthal AN; Oram DH; Knapp RC; Jacobs IJ
J Clin Oncol; 2003 May; 21(10 Suppl):206s-210s. PubMed ID: 12743136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
